GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Talphera Inc (FRA:R5XA) » Definitions » Float Percentage Of Total Shares Outstanding

Talphera (FRA:R5XA) Float Percentage Of Total Shares Outstanding : 87.28% (As of Jun. 09, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Talphera Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Talphera's float shares is 14.83 Mil. Talphera's total shares outstanding is 16.99 Mil. Talphera's float percentage of total shares outstanding is 87.28%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Talphera's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Talphera's Institutional Ownership is 2.80%.

Talphera Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Talphera's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=14.83/16.99
=87.28%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Talphera (FRA:R5XA) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Talphera Inc (FRA:R5XA) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
UNRV RLBD SBFM GHSI SHPH BUDZ FLGC CVSI DMK BFRI ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
TLPH:USA
Address
25821 Industrial Boulevard, Suite 400, Hayward, CA, USA, 94545
Website
https://www.acelrx.com
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings. Its product portfolio includes Niyad that is a lyophilized formulation of nafamostat. It is also developing two pre-filled syringes, a pre-filled ephedrine syringe, and PFS-02, a pre-filled phenylephrine syringe.

Talphera (FRA:R5XA) Headlines

No Headlines